Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone45-3917-7300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.21 billion
Profitability
Miscellaneous
Employees14,614
Next Earnings DateN/A
OptionableNot Optionable
DEMANT A S/ADR (OTCMKTS:WILYY) Frequently Asked Questions
What is DEMANT A S/ADR's stock symbol?
DEMANT A S/ADR trades on the OTCMKTS under the ticker symbol "WILYY."
Has DEMANT A S/ADR been receiving favorable news coverage?
Press coverage about WILYY stock has been trending very negative recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. DEMANT A S/ADR earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for DEMANT A S/ADR.
Who are some of DEMANT A S/ADR's key competitors?
Some companies that are related to DEMANT A S/ADR include Smith & Nephew (SNN), Align Technology (ALGN), Steris (STE), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX), ConforMIS (CFMS), Lakeland Industries (LAKE), Histogenics (HSGX) and Rewalk Robotics (RWLK).
What other stocks do shareholders of DEMANT A S/ADR own?
Who are DEMANT A S/ADR's key executives?
DEMANT A S/ADR's management team includes the folowing people:
- Mr. Søren Nielsen, CEO, Pres & Member of Exec. Board (Age 49)
- Mr. René Schneider, CFO & Member of Exec. Board (Age 46)
- Mr. Søren Bergholt Andersson, VP of Investor Relations (Age 42)
- Ms. Trine Kromann-Mikkelsen, VP of Corp. Communication & Relations
- Mr. Jes Olsen, Pres of Oticon Medical
How do I buy shares of DEMANT A S/ADR?
Shares of WILYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is DEMANT A S/ADR's stock price today?
One share of WILYY stock can currently be purchased for approximately $12.21.
How big of a company is DEMANT A S/ADR?
DEMANT A S/ADR has a market capitalization of $5.99 billion and generates $2.21 billion in revenue each year. The company earns $288.76 million in net income (profit) each year or $0.58 on an earnings per share basis. DEMANT A S/ADR employs 14,614 workers across the globe.View Additional Information About DEMANT A S/ADR.
What is DEMANT A S/ADR's official website?
How can I contact DEMANT A S/ADR?
DEMANT A S/ADR's mailing address is Kongebakken 9, Smorum G7, 2765. The company can be reached via phone at 45-3917-7300 or via email at [email protected]
MarketBeat Community Rating for DEMANT A S/ADR (OTCMKTS WILYY)
MarketBeat's community ratings are surveys of what our community members think about DEMANT A S/ADR and other stocks. Vote "Outperform" if you believe WILYY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WILYY will underperform the S&P 500 over the long term. You may vote once every thirty days.
